Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

How distress alters opioid drug effects and abuse liability

Project description

Opioids may be more addictive for people who are socially distressed

Significant research has shown that close social bonds are important for a happy and fulfilled life but few have explored the underlying neural mechanisms. As the opioid crisis reaches epidemic proportions, natural opioids in the brain have gained increased attention. The brain opioid theory of social attachments suggests that opioids are responsible for the pleasurable satisfaction that comes with social connection and bonding. Conversely, social loss or separation can reduce brain opioid activity. OPIOIDREWARD is undertaking pioneering human experiments to determine if pre-existing social distress is a risk factor for opioid abuse. Computational modelling and functional imaging will complement behavioural data. Outcomes could lead to preventive screening and perhaps a break in the cycle of addiction and death.

Objective

As the opioid epidemic escalates, we must ask: why are opioids so addictive? Non-human animal research links addiction with the powerful relief opioids can offer to animals in distress. In humans, epidemiological and clinical studies converge upon social stressors and a poor social support network as key risk factors for addiction. Despite this, it is currently unknown how pre-drug distress might alter opioid drug effects. Tremendous resources are dedicated to charting how people feel after taking a drug, sidestepping the potentially profound influence of how people feel before they take the drug. Here, I will turn the current approach on its head. Using acute social distress induction before morphine administration in healthy humans, I will create a human model to determine the psychological, physiological and brain underpinnings of how social stressors increase opioids’ abuse liability.

First, I will test the hypothesis that pre-drug distress enhances drug wanting (self-administration) but not drug liking (self-report) compared to drug effects in a control condition. Second, I will use opioid blockade to confirm or falsify the hypothesis that opioid drugs ‘hijack’ brain mechanisms underpinning social support. Third, I will determine to what extent opioid drug effects are dopamine-dependent by blocking dopamine before morphine administration. I will also apply computational modelling and functional imaging to elucidate the underlying brain mechanisms. Thus, the proposal offers a powerful new methodology for resolving hotly debated questions on the independent contributions of opioids and dopamine for reward and abuse liability.

In sum, the project aims to achieve a breakthrough in our understanding of how a pre-drug social distress state can alter opioid drug mechanisms. The mechanistic understanding arising from this project could have profound implications for science, as well as for clinical care and new policies designed to contain the opioid epidemic.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

ERC-STG - Starting Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2018-STG

See all projects funded under this call

Host institution

UNIVERSITETET I OSLO
Net EU contribution
€ 1 436 014,00
Address
PROBLEMVEIEN 5-7
0313 Oslo
Norway
Region
Norge Oslo og Viken Oslo
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 500 000,00

Beneficiaries (2)